Bavarian Nordic
0 sources
Summary
Bavarian Nordic is a business[1]. It ranks in the top 4% of business entities by monthly Wikipedia readership (436 views/month).[2]
Key Facts
- Located in the administrative territorial entity: Gentofte Municipality[3]
- Country: Denmark[4]
- Instance of: public company[5]
- Owned by: Arbejdsmarkedets Tillægspension[6]
- Headquarters location: Hellerup[7]
- Chief executive officer: Paul Chaplin[8]
- Child organization or unit: Bavarian Nordic (United States)[9]
- Part of: Stoxx Europe 600 Index[10]
- Stock exchange: Nasdaq Copenhagen A/S[11], OTC Markets Group[12]
- Industry: biotechnology[13]
- Inception: July 1, 1992[14]
- Official website: https://www.bavarian-nordic.com[15]
- Product or material produced: smallpox vaccine[16]
- Employees: 1653[17]
- Legal form: aktieselskab[18]
- Total equity: 7,374,667,000 Danish krone[19], 11,409,000,000 Danish krone[20]
- Total revenue: 1,938,362,000 Danish krone[21], 5,716,000,000 Danish krone[22]
- Total assets: 12,107,828,000 Danish krone[23], 14,406,000,000 Danish krone[24]
- P14750: 796A-46E7-D725-7FB1-ECAC[25]
Why It Matters
Bavarian Nordic has Wikipedia articles in 5 language editions, a strong signal of global cultural recognition.[26] It is known by 17 alternative names across languages and contexts.[27]